Hongbo Lu - 18 Mar 2024 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role: Director
Signature: /s/Hongbo Lu
Issuer symbol: ARWR
Transactions as of: 18 Mar 2024
Net transactions value: +$82,990
Form type: 4
Filing time: 20 Mar 2024, 19:06:58 UTC
Previous filing: 18 Mar 2024
Next filing: 14 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARWR	Common Stock	Purchase	$27,490	+1,000	+3.3%	$27.49	31,680	18 Mar 2024	Direct	F1
transaction	ARWR	Common Stock	Purchase	$28,000	+1,000	+3.2%	$28.00	32,680	19 Mar 2024	Direct
transaction	ARWR	Common Stock	Purchase	$27,500	+1,000	+3.1%	$27.50	33,680	20 Mar 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported on Column 4 is the weighted average price. These shares were purchase in multiple transactions at prices ranging from $ 27.48 to $ 27.50, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.

Content

The price reported on Column 4 is the weighted average price. These shares were purchase in multiple transactions at prices ranging from $ 27.48 to $ 27.50, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.